Musculoskeletal
Rib Fracture
31
Pipeline Programs↗
9
Active Trials↗
13
Companies Involved↗
Rib Fracture is a moderately active landscape with 31 programs across 13 companies. The most active players are Viatris Specialty LLC, Hikma Pharmaceuticals LLC, Pfizer. 18 therapies are approved with 3 more in late-stage development.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical6
Phase 12
Analysis
Trial Status
37
clinical trials
Terminated10 · 27%
Completed9 · 24%
Unknown status5 · 14%
Recruiting4 · 11%
Withdrawn4 · 11%
Active, not recruiting2 · 5%
Other3 · 8%
Clinical Trials
Trial Activity
37 trials
INTERCOSTAL NERVE BLOCK: Efficacy of CINB for Patients With Multiple Rib Fractures
Recruiting·—·Phase 4·NCT05642026·180 enrolled
Ketamine vs Lidocaine in Traumatic Rib Fractures
Active, not recruiting·—·Phase 4·NCT04781673·74 enrolled
Role of Nerve Block in Management of Multiple Rib Fractures
Not yet recruiting·—·Phase 4·NCT06958549·74 enrolled
Efficacy of Gabapentin vs. Placebo for Adjuvant Pain Control Following Acute Rib Fractures
Completed·—·Phase 1·NCT02856750·100 enrolled
Lidocaine Spray for Pain Control in Rib Fractures
Completed·—·Phase 4·NCT05500677·48 enrolled
Page 1 of 3
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)